Sign in

Chris Ashwood

@cashwood.proteaglyco.com
1.5K followers 968 following 1.8K posts

Director of Protea Glycosciences Accelerating glycoscience research

PostsRepliesMedia
Chris Ashwood @cashwood.proteaglyco.com · 7h
It was great to attend #HUPO2026 and catch up with new friends and old. Here's our (@maiakelly.bsky.social) main poster for the conference, achieving the most comprehensive representation of the glycome to date with N-, O-, GSL-, and free- glycans acquired in a single LC-MS run. #glycotime
150
Reposted by Chris Ashwood
BioF:GREAT @biof-great.bsky.social · 29/09/2026
🧪 Need specialized sugar donors for your research? BioF offers NDP sugars, sugar analogs & derivatives for glycoscience research—with custom synthesis and bulk quantities available. 🍬 Democratizing Glycoscience. biofgreat.org/donors/ #biofgreat #nsf #teledyne #glycotime
biofgreat.org
NDP sugars and derivatives
NDP sugars and derivatives — Glycoscience Research, Education and Training — democratizing glycoscience by increasing accessibility to research, education and training
012
Reposted by Chris Ashwood
Rita Strack @ritastrack.bsky.social · 29/09/2026
We've had a wave of source data corrections lately across the Nature Portfolio. We wrote an editorial about the importance of bookkeeping and QC when preparing manuscripts. www.nature.com/articles/s41...
nature.com
Source data under scrutiny - Nature Biomedical Engineering
The source data underlying results and figures in our manuscripts can be critical for assessing the rigour of our studies and for reproducibility. Ensuring the quality and provenance of these data dur...
1229
Chris Ashwood @cashwood.proteaglyco.com · 27/09/2026
One thing I don’t see enough of, on social media, for these conferences is SWAG. Please find below what I’ve found so far at #HUPO2026
151
Reposted by Chris Ashwood
The NCFG @thencfg.bsky.social · 24/09/2026
Did you know carbohydrates can modify 10 of the 20 amino acids, from GlcNAc-Tyr in tumor cells to Glc-Arg in bacterial signaling? Find out about more: research.bidmc.org/ncfg/blog/30... #glycobiology #biochemistry #proteomics #posttranslationalmodification #cellbiology #glycotime
research.bidmc.org
30] Unusual Modification of Peptides/Proteins with Sugars
052
Reposted by Chris Ashwood
Sweet Papers 🤖 @sweetpapers.proteaglyco.com · 24/09/2026
Human NEU3 and NEU4 enzymes prefer short polysialic acid substrates #glycotime #CarbohydrateResearch
sciencedirect.com
Human NEU3 and NEU4 enzymes prefer short polysialic acid substrates
text/html; charset=UTF-8
043
Reposted by Chris Ashwood
Paul Daly @paulsh02.bsky.social · 24/09/2026
Please see our latest Biotechnology Advances review on cell wall degrading CAZymes in biocontrol of fungal- and oomycete-caused crop diseases. With Irina Druzhinina @rbgkew.bsky.social and colleagues from Cranfield Uni. (This share link works until Nov 11th) authors.elsevier.com/a/1nqM22d7Ir...
021
Reposted by Chris Ashwood
Noelle Held @proteocean.bsky.social · 23/09/2026
We are still looking for a postdoc to work on molecular underpinnings of nitrogen fixation in the South Pacific, with potential to inform approaches to mCDR. Please share! proteoceanlab.github.io/assets/img/2...
proteoceanlab.github.io
0911
Reposted by Chris Ashwood
ASMS @asms.org · 21/09/2026
The September 30 deadline to submit to the @jasms.bsky.social Carbohydrates Special Issue is approaching. Working in glycomics, glycobioinformatics, or other areas of carbohydrate-focused mass spectrometry? We want to see your research! Submit by September 30, 2026! bit.ly/4gvFzbI
022
Reposted by Chris Ashwood
Joost Snijder @joostsnijder.bsky.social · 21/09/2026
Time for our Advanced BioMS course this week! Here’s Kelly kicking things off.
031
Reposted by Chris Ashwood
Marcin Czerwinski @czerwinsmarcin.bsky.social · 21/09/2026
How to study glycosylation using bioorthogonal glycan-based tools: now in one comprehensive review. Highly recommended! tinyurl.com/27z2rhvv #glycotime
1149
Reposted by Chris Ashwood
Joe Bak-Coleman @jbakcoleman.bsky.social · 20/09/2026
To the original argument, Solving complex problems does not require thinking or understanding. It’s not a dichotomy whereby either humans have souls or whatever. It’s entirely possible that, say, thought as we experience it is a spandrel. en.wikipedia.org/wiki/Spandre...
en.wikipedia.org
Spandrel (biology) - Wikipedia
1119724
Reposted by Chris Ashwood
Sweet Papers 🤖 @sweetpapers.proteaglyco.com · 17/09/2026
<em>Shigella</em> O-Antigen Diversity and Evolution: Comprehensive Analysis and Development of ShigO3D, a Three-Dimensional Structural Repository #glycotime #CarbohydrateResearch
sciencedirect.com
<em>Shigella</em> O-Antigen Diversity and Evolution: Comprehensive Analysis and Development of ShigO3D, a Three-Dimensional Structural Repository
text/html; charset=UTF-8
011
Reposted by Chris Ashwood
Ben Schumann @drglycoben.bsky.social · 17/09/2026
⚠️ 🥳 check out our new pre-print led by the fantastic @sophiedschmidt.bsky.social: An in vivo chemical genetic approach for targeted glycoproteome analysis in Drosophila melanogaster: www.biorxiv.org/content/10.6... We present FlyMOE, a strategy for targeted glycoprotein profiling in vivo.
biorxiv.org
An in vivo chemical genetic approach for targeted glycoproteome analysis in Drosophila melanogaster
Glycans impact every aspect of physiology. Despite the rapid increase in relevance and translational potential, there remains a lack of tools for studying glycosylation in vivo. Here, we present FlyMO...
196
Reposted by Chris Ashwood
Karim Majzoub @karimaj.bsky.social · 17/09/2026
@jeremydufloo.bsky.social had a brief and productive visit to our lab one summer ago and he came up with this discovery : Glycosphingolipids are essential entry factors for non-influenza orthomyxoviruses
microbiologyresearch.org
Glycosphingolipids are essential entry factors for non-influenza orthomyxoviruses
Thogotoviruses and quaranjaviruses are arthropod-borne orthomyxoviruses that circulate widely in wildlife and domestic animals and include several zoonotic members. Despite their close phylogenetic re...
032
Reposted by Chris Ashwood
Lorna Milne @lornamilne.bsky.social · 17/09/2026
SO excited to be teaming up with @j-a-n-alexander.bsky.social to chair next years Glycobiology GRS! 🍬 Welcoming abstracts from all areas of #glycotime - we can't wait to see you all in Ventura! 🌞
141
Reposted by Chris Ashwood
Prof. Gavin Reid @gurugav69.bsky.social · 16/09/2026
For academics in Australia who are eager to know more about the new Australian Research Council National Competitive Grants Program schemes, the Grant Guidelines for the new Explore scheme were presented to the Senate as a disallowable instrument on Sept. 14. www.legislation.gov.au/F2026L01187/...
legislation.gov.au
031
Reposted by Chris Ashwood
Elisa Fadda @elisafadda.bsky.social · 14/09/2026
🚨 Want to be part of top #glycotime on the seaside in the California sunshine? Register to the 2027 GRC Glycobiology ⬇️ Stacy and Lance put togteher up one of the most exciting programmes I have ever seen with phenomenal keynotes! We have 32 abstracts to select, so the next speaker could be YOU! 😎
Announcement of the GRC Glycobiology 2027 to be held in Ventura CA on March 14 to 19, 2027. Blue background with an photo of Ventura from the visitventuraca.com
11412
Reposted by Chris Ashwood
Kermit Murray @kkmurray.bsky.social · 15/09/2026
Cryo-EM sample preparation with soft-landing and laser flash melting #nature #MassSpecRSS
dlvr.it
Cryo-EM sample preparation with soft-landing and laser flash melting - Nature Communications
Laser flash melting of a cryo-EM sample that is prepared by soft-landing mass spectrometry and subsequent deposition of amorphous ice restores some particles to near-native shape, pointing towards more reliable cryo-EM sample preparation.
031
Reposted by Chris Ashwood
Marcin Czerwinski @czerwinsmarcin.bsky.social · 15/09/2026
The ISBT Blood Group Database: A digital resource for classifying blood groups in the genomic era. onlinelibrary.wiley.com/doi/10.1111/...
onlinelibrary.wiley.com
The <fc>ISBT</fc> Blood Group Database: A digital resource for classifying blood groups in the genomic era
Click on the article title to read more.
021
Reposted by Chris Ashwood
The NCFG @thencfg.bsky.social · 14/09/2026
As the field advances, several original ideas change as more information is gathered. In this article by Dr. Richard Cummings, he discusses the changes over the years in 50 paradigms in Glycobiology comparing prior and new paradigms. Read at academic.oup.com/glycob/advan... #glycotime #glycobiology
022
Chris Ashwood @cashwood.proteaglyco.com · 14/09/2026
Recently, we evaluated DIA compared to DDA and our real-time glycomics method (basically, inclusion list-based DDA). DIA doesn't give us the sensitivity we need for structure. One benefit of DDA (or GlycoRTMS) is that it can accumulate for long time compared to the comprehensive but insensitive DIA
GlycoRTMS provides greater precursor-specific MS² spectral depth than DDA and DIA. A Comparison of MS² acquisition parameters; DIA used 68 m/z isolation windows across 570–1800 m/z to maintain cycle time. B Apex MS² spectra of the same biantennary disialylated N-glycan, showing increased spectral complexity with DIA. C Product-ion intensity distributions showing composition-confirming ions across methods, while lower-abundance structurally informative ions were detected only by GlycoRTMS.
0202
Reposted by Chris Ashwood
Sweet Papers 🤖 @sweetpapers.proteaglyco.com · 13/09/2026
Defined O-acetylated Neu5Ac substrates reveal position-specific preferences of gut bacterial sialidases #glycotime #Glycobiology
academic.oup.com
Defined O-acetylated Neu5Ac substrates reveal position-specific preferences of gut bacterial sialidases
text/html; charset=UTF-8
011
Reposted by Chris Ashwood
Hiren Joshi @glyco.me · 11/09/2026
The 5 use-cases tell a story. Two of them are grant applications, I find that hard to see as threatening. So then there is avian flu adaptation, the peptide atlas and toxin redesign. I can see how legitimate lines of investigation could have triggered this.
anthropic.com
Countering misuse of AI: September 2026 / Anthropic
Case studies from threat actors disrupted between December 2025 and August 2026 across seven areas of harm, from cyber operations to biological misuse.
121
Reposted by Chris Ashwood
Kermit Murray @kkmurray.bsky.social · 10/09/2026
(RCM) Advances in the Design and Functionality of a Compact Multi‐Reflecting Time‐of‐Flight Mass Spectrometer: ABSTRACT Rationale High-resolution mass spectrometry is routinely used for the analysis of complex samples in pharmaceutical, environmental,… #RapidCommunMassSpectrom #MassSpecRSS
dlvr.it
Advances in the Design and Functionality of a Compact Multi‐Reflecting Time‐of‐Flight Mass Spectrometer
ABSTRACT Rationale High-resolution mass spectrometry is routinely used for the analysis of complex samples in pharmaceutical, environmental, and omics related studies. Such applications demand instrumentation to be capable of combining sub-ppm mass accuracy, high resolving power, rapid full m/z range acquisition over a wide dynamic range. Methods Achieving the above requirements places constraints on analyzer design and performance. Multi-reflecting time-of-flight (MRT) based analyzers have previously been reported as a means of significantly extending the effective flight path in compact TOF designs. Here, further instrument and functionality advances in a compact MRT mass spectrometer design are described. Results The impact of these enhancements was assessed for targeted and non-targeted omics applications, examining the impact of acquisition speed on resolving power, dynamic range including limits of quantitation, and quantitative precision. Conclusion The results obtained characterize the performance of the enhanced design features of a compact MRT mass spectrometer. Operation at elevated acquisition rates up to 200 Hz was observed without loss in resolving power, isotopic ratio accuracy or quantitative precision.
021
Reposted by Chris Ashwood
Alejandra Caraballo @esqueer.net · 10/09/2026
Looks like OpenAI may have stolen another mathematicians work.
Screenshot of an X post by user Valerio Capraro (@ValerioCapraro) featuring text followed by an embedded photo of a man in glasses and a dark sweater against a forested outdoor background.
The post text reads:
"BREAKING: OpenAI might have stolen another major proof.
In a detailed Mastodon post, which I report in full in the comments, Andreas Thom presents several pieces of evidence suggesting that OpenAI may have trained Astra on conversations in which he and Gábor Kun were working on Gromov's soficity conjecture, one of the ten problems OpenAI later announced Astra had solved.
I know Andreas. We met several times early in our careers. He is an exceptional mathematician, a leading expert on sofic and hyperlinear groups, and one of the most respected scholars in the field. He has spent two decades working on this problem.
If his account is correct, this is not a minor dispute over attribution. It would mean that unpublished human work was absorbed into a model and then presented to the world as a breakthrough by the model itself.
And if the allegations raised by Levent Alpöge, Tristan Buckmaster, and now Andreas Thom are all substantiated, we are no longer looking at isolated incidents.
We may be looking at one of the greatest intellectual scandals in the history of science.
AI is not discovering new mathematics.
AI is stealing human discovery."
20847287
Chris Ashwood @cashwood.proteaglyco.com · 09/09/2026
That’s some pretty high res mass photometry! It’s a very clean distribution which makes the interpretation clear.
000
Reposted by Chris Ashwood
Kermit Murray @kkmurray.bsky.social · 09/09/2026
(Angew Chem) Beyond the Fixed Charge: A New On‐Tissue Derivatisation Strategy Employing Photoionisable Chromophores for Mass Spectrometry Imaging of Amino‐Containing Metabolites: We introduce a novel chemical derivatisation strategy for the UV-activated detection of… (RSS) #AngewChem #MassSpecRSS
dlvr.it
Beyond the Fixed Charge: A New On‐Tissue Derivatisation Strategy Employing Photoionisable Chromophores for Mass Spectrometry Imaging of Amino‐Containing Metabolites
We introduce a novel chemical derivatisation strategy for the UV-activated detection of elusive metabolites. Incorporation of a tocopherol-active chromophore allows for the detection of tagged analytes as photoionised radical cations, selectively induced by a 266 nm laser. Furthermore, high spatially resolved imaging of metabolites has been demonstrated across multiple tissue types. ABSTRACT Matrix-assisted laser desorption/ionisation mass spectrometry imaging (MALDI-MSI) has been widely adopted for the spatially resolved mapping of chemical composition within biological tissues. However, inherent limitations in ionisation efficiencies limit the scope of analyte detection. Currently, methods to enhance molecular coverage have focused on chemical derivatisation of target analyte classes or post-ionisation techniques, namely, laser post-ionisation (MALDI-2). Previously, we observed that under reduced laser fluence conditions, MALDI-2 can be utilised to selectively enhance photoionisation of aromatic analytes. Leveraging these observations, we have conducted a proof-of-concept study to establish a conceptually novel class of derivatisation reagents, employing a tocopherol active chromophore O-linked succinimide (TAC/OS) for the selective derivatisation of primary amines. Using TAC/OS, amino metabolites were selectively detected as the derivatised radical cations in the presence of MALDI-2. Across three tissue types, over 30 metabolites were detected and localised, including 20 amino acids alongside neurotransmitters such as γ-aminobutyric acid (GABA) and dopamine. Imaging at 10 µm pixel size revealed minimal delocalisation, allowing for MSI at near single-cell resolution. Furthermore, we demonstrated the ability of the developed protocol on late-stage pancreatic cancer xenografts.
131
Chris Ashwood @cashwood.proteaglyco.com · 08/09/2026
Discussed this with a colleague recently. If you don’t have a business account with zero data retention, there is no way to confirm that your data isn’t being used to “improve the models”. Niche spaces are likely safe, but this is a good example below where marketing trumps customer privacy.
142
Chris Ashwood @cashwood.proteaglyco.com · 08/09/2026
Opentrons sure has advanced beyond its initial modules. Last week they announced an automated vacuum filtration module, it would be particularly useful for any plate-based preps for proteomics/glycomics. www.youtube.com/watch?v=3CCL...
youtube.com
Introducing the Opentrons Flex Vacuum Module | Automated Filtration & Sample Cleanup
YouTube video by Opentrons Labworks
020
Reposted by Chris Ashwood
ARC Tracker @arc-tracker.bsky.social · 07/09/2026
ARC says they'll announce outcomes of Future Fellowships (FT26) tomorrow (Tue 8 Sep). In recent times, these announcements have been around 11am Canberra time, though certainly with some variation. My bot will automatically post within a minute after the announcement.
64713
Reposted by Chris Ashwood
Samuel A. Myers' lab @samyers-lab.bsky.social · 06/09/2026
With the sensitivity of modern LC-MS, analyzing changes in protein complexes across differing biological systems will lead to false positives from the background proteomes. We provide some work arounds This also allowed us to identify interesting biology concerning OGT-protein complexes #glycotime
163
Reposted by Chris Ashwood
Marcin Czerwinski @czerwinsmarcin.bsky.social · 04/09/2026
Interesting! α-Gal–specific mAbs from B cells of individuals who have been exposed to malaria suppress the activation of basophils sensitized with serum from patients with α-Gal syndrome. New intervention to prevent α-Gal allergy? tinyurl.com/yr5hsssr #glycotime
141
Reposted by Chris Ashwood
GlycoShape @glycoshape.org · 04/09/2026
🚨 New version of GlycoShape is now live at glycoshape.org 🥳 Powered by crabWURCS everything runs on your browser and while you save all you ReGlyco work and go back to it whenever you like 😎 Among other new things: new slick drawer, much easier to use, new slick SNFG representations and new layout
screenshot to represent the new layout of GlycoShape, here the database screen added NEW sticker
1146
Reposted by Chris Ashwood
Australian BioCommons @ausbiocommons.bsky.social · 03/09/2026
Looking forward to welcoming Emeritus ProfTony Bacic, @latrobe.edu.au and Dr @oliverberkowitz.bsky.social to our next #Genomics Community Meeting on Tue 15 Sept. They'll be presenting on 'BPA Protein Atlas: Why? Improving the Nutrition and Sensory Qualities of Legumes & Legume-Based Foods' 🔗
biocommons.org.au
MEETING: Genomics community — Australian BioCommons
Join researchers, scientists and bioinformaticians to discuss genomics research in Australia More information
021
Reposted by Chris Ashwood
Kate Michie @kmichie.bsky.social · 03/09/2026
ProteinDJ v3.0 is free for commercial use! Built by @joshuamhardy.bsky.social (WEHI), with contributions from @tlitfin.bsky.social and David Ladd (Audax). Commercial deps removed. New: GPU design/relaxation, BoltzGen, AF2/Boltz2 tandem and insulin-receptor binder tutorial. github.com/PapenfussLab...
Protein DJ code's logo (protein structure in white on blue) with contributors logos- WEHI (main development) and UNSW, Australian Biocommons and Audax contributions.
0132
Reposted by Chris Ashwood
Chemistry World @chemistryworld.com · 01/09/2026
Laboratories can be inherently hazardous environments but what does this mean when you’re expecting? Join us next week for an important conversation on the challenges facing pregnant chemists & changes needed to build support. Register here👇 @rsc.org #ChemSky www.chemistryworld.com/webinars/wor...
chemistryworld.com
Working safely through pregnancy: a conversation for chemists and lab leaders
How safe is the lab when you're pregnant? Join our conversation on 9 September
054
Chris Ashwood @cashwood.proteaglyco.com · 31/08/2026
Thanks to valuable reviewer feedback, we've updated our GlyComboCLI software (and accompanying preprint) which includes: • GlyTouCan integration for glycan compositions • Strengthened software distribution and reproducibility • Expanded biological validation www.biorxiv.org/content/10.6...
New Figure 3 GlyComboCLI reproduces qualitative and quantitative features of a published human serum N-glycome. A Venn diagram comparing glycan compositions reported in the original study with GlyComboCLI assignments following isotopic-envelope filtering. B Rank trajectory plot comparing glycan abundance ranks derived from published glycan intensities, GlyComboCLI MS2 scan total ion current, and Skyline MS1 peak-area integration.
110
Reposted by Chris Ashwood
Philipp Lange (he/him) @philipplange.bsky.social · 31/08/2026
New preprint form the lab - Single-Cell proteomics discerns patient-specific subpopulations in pediatric B-cell acute lymphoblastic leukemia www.biorxiv.org/content/10.6...
162
Reposted by Chris Ashwood
BCCHR ResDev (DM) @resdevbcch.bsky.social · 28/08/2026
dear Canadian grant reviewers and international reviewers of Canadian grants: NOPE NOPE NOPE federal policy prohibits use of AI for grant review. **please respect the privacy / confidentiality of your peers** thank you!
63723
Reposted by Chris Ashwood
James Murphy @pseudokinase.bsky.social · 28/08/2026
Wonderful to share our new study! science.org/doi/10.1126/sc… Patients can look well-controlled and still have epithelial death programs running. We found it in nascent IBD lesions on advanced therapy and it flagged who relapsed over 2–3 years. @WEHI_research @NHMRC #ScienceResearch
science.org
1145
Chris Ashwood @cashwood.proteaglyco.com · 27/08/2026
#glycotime
000
Reposted by Chris Ashwood
Kermit Murray @kkmurray.bsky.social · 26/08/2026
(BioRxiv All) Site-specific processing of phosphoethanolamine cellulose by the BcsZ cellulase reveals stochastic biofilm cellulose modification: Cellulose is a common component of bacterial biofilms where it interacts with other biopolymers to form a 3-dimensional matrix… #BioRxiv #MassSpecRSS
dlvr.it
Site-specific processing of phosphoethanolamine cellulose by the BcsZ cellulase reveals stochastic biofilm cellulose modification
Cellulose is a common component of bacterial biofilms where it interacts with other biopolymers to form a 3-dimensional matrix enclosing the bacteria. Synthesized and secreted by the synthase-dependent biosynthesis pathway common to many bacterial exopolysaccharides, its surface exposure depends on the presence of the periplasmic cellulase BcsZ. During export across the periplasm, E. coli and other Enterobacteriaceae modify cellulose with lipid-derived phosphoethanolamine (pEtN). How BcsZ hydrolyzes pEtN-cellulose in the periplasm is unknown and so is the native distribution pattern of pEtN on cellulose. Here, we used carbohydrate synthesis, X-ray crystallography, native mass spectrometry, and super-resolution MINFLUX nanoscopy to delineate the role of BcsZ during cellulose biosynthesis. Crystal structures of BcsZ bound to chemically synthesized pEtN cello-oligosaccharides identify how the enzyme recognizes pEtN-modified glucosyl units. Comparing mono and double substituted cellohexaoses, we identify varying binding poses that are determined by two pEtN coordination sites within the BcsZ catalytic pocket. Combined, our structural analyses reveal an ideal BcsZ cellohexaose ligand containing two pEtN modified units separated by an unmodified cellotriosyl unit. The enzyme binds and hydrolyzes this compound with substantially increased affinity and efficiency. Further, BcsZ digestion of native pEtN cellulose combined with native mass spectrometry analyses reveals the stochastic distribution of pEtN on biofilm cellulose. Additionally, MINFLUX co-localization of BcsZ with other components of the biosynthetic complex demonstrates the random distribution of BcsZ across the periplasm. Our data suggest BcsZ functions independently of the biosynthetic complex to clear mislocalized pEtN cellulose from the periplasm.
021
Chris Ashwood @cashwood.proteaglyco.com · 26/08/2026
“This Perspective proposes a model-to-mechanism burden of proof that distinguishes prediction from explanation, imputation from observation, attribution from causality, cross-layer coherence from mechanism, and diagnostic performance from biological validity.”
static.klipy.com
Can't Read Sign Meme
ALT: Can't Read Sign Meme
223
Reposted by Chris Ashwood
Kyle Griffin @kylegriffin1.bsky.social · 25/08/2026
Reminder: Dolly Parton helped fund the Moderna vaccine for COVID.
nytimes.com
Dolly Parton, who helped fund the Moderna vaccine, gets a ‘dose of her own medicine.’ (Published 2021)
The country music star broke into song before she was inoculated, and urged her fans to “get out there and get your shot.”
247238655776
Reposted by Chris Ashwood
Joost Snijder @joostsnijder.bsky.social · 23/08/2026
Check out this cool new reference free assembler for mass spec-based de novo protein sequencing by @lukaskall.bsky.social www.biorxiv.org/content/10.6...
biorxiv.org
083
Reposted by Chris Ashwood
Jeremy Kamil @macroliter.bsky.social · 23/08/2026
🧪 🎁 🔗
nytimes.com
Maura L. Gillison, Who Linked Throat Cancers to HPV, Dies at 61 (Gift Article)
She challenged the conventional view that most head and neck cancers resulted from cigarette smoking and excessive alcohol consumption.
65221
Reposted by Chris Ashwood
IMProGlyco @improglyco.bsky.social · 20/08/2026
🔬 Research Highlight Congratulations to IMProGlyco partner Niclas Karlsson and co-authors on their publication describing FILA and FLA, two methods for glycomic discovery and validation. Great work by the team 👏 🔗 doi.org/10.1016/bs.m... #IMProGlyco #Glycomics
doi.org
Redirecting
022
Reposted by Chris Ashwood
SFG @sfglycobiology.bsky.social · 20/08/2026
MEET SOME OF THE SFG 2026 SPEAKERS! Featuring Sessions 4 – 6. Hear from leading voices advancing glycobiology at SFG 2026! Stay connected as we introduce more Scientific Program Speakers. IMPORTANT: Aug. 21 is the Early Bird Rates and Abstracts Deadline. sfg.memberclicks.net/registration...
011
Reposted by Chris Ashwood
GlycoNAVI @glyconavi.bsky.social · 20/08/2026
Webinar: How to use GlycanBuilder recording is now available on GlyCosmos YouTube channel! youtu.be/ftJGmyca2Lc?... Thank you to everyone who attended, and don't forget to leave us a feedback (or two!) and participate in our survey about GlycanBuilder usage!!
youtu.be
Webinar: How to use GlycanBuilder
YouTube video by GlyCosmosChannel
131